Rachel Stevens
Overview
Explore the profile of Rachel Stevens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Stevens R, Almanaseer I, Gonzalez M, Caglar D, Knudson R, Ketterling R, et al.
J Mol Diagn
. 2007 Mar;
9(2):144-50.
PMID: 17384205
The HER2 gene, amplified in 10 to 35% of invasive human breast carcinomas, has prognostic and therapeutic implications. Fluorescent in situ hybridization is one method currently used for assessing HER2...
12.
Whetten K, Reif S, Swartz M, Stevens R, Ostermann J, Hanisch L, et al.
AIDS Patient Care STDS
. 2005 Feb;
19(2):89-99.
PMID: 15716640
Mental illness and substance abuse are common among HIV-infected individuals and are associated with negative outcomes, including poor medication adherence. Therefore, quick and effective methods for detecting these co-occurring disorders...
13.
Irwin D, Millikan R, Stevens R, Roche M, Rakhra-Burris T, Davis M, et al.
J Public Health Manag Pract
. 2005 Jan;
10(6):539-44.
PMID: 15643378
In order to examine the extent to which current public health practices incorporate information about genetic susceptibilities potentially obtained by a comprehensive family history, public health nurses in North Carolina...
14.
Mays G, Halverson P, Baker E, Stevens R, Vann J
Am J Public Health
. 2004 Jul;
94(6):1019-26.
PMID: 15249309
Objectives: We examined the availability and perceived effectiveness of 20 basic public health activities in the communities where most Americans reside. Methods: A self-administered questionnaire was mailed to the 497...
15.
Bhamra R, Bolcsak L, Ahmad I, Schupsky J, Roberts P, Stevens R, et al.
Anticancer Drugs
. 2003 Jul;
14(6):481-6.
PMID: 12853892
TLC ELL-12 is a liposomal formulation of the novel antineoplastic compound 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (L-ET-18-OCH(3)). The purpose of these studies was to evaluate the activity and tissue distribution of L-ET-18-OCH(3) when administered...
16.
Bhamra R, Bolcsak L, Roberts P, Stevens R, Cavanaugh C, Swenson C
Anticancer Drugs
. 2003 Mar;
14(3):183-91.
PMID: 12634612
TLC ELL-12 is a liposomal formulation of the antineoplastic L-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine [L-ET-18-OCH3 (EL)]. The purpose of these studies was to characterize the toxicity and disposition of [N-methyl-14C] L-ET-18-OCH3 administered as TLC...